A welcome letter from ACT's Publisher Wayne Blow
Dear Colleague,
Welcome to the Applied Clinical Trials' Directory & Buyers' Guide for 2006. Enclosed within these pages is a comprehensive list of key leaders and resources in the clinical trials industry. We know you will find a great deal of information to facilitate your search for suppliers and outsourcers of Clinical Packaging, Consulting, CROs, Contract Research Services, Information Technology, IRBs, Laboratories and Laboratory Supplies, Subject Recruitment, and Training and Education within the industry.
Wayne K. Blow
The clinical trials community is continually growing, and it is important to keep up with the changing environment. The purpose of this directory and buyers' guide is to keep you abreast of the changes taking place, whether they are in clinical trials monitoring, specialty labs, EDC suppliers, software developers or training and education. Clinical trials require strategic partners and outsourcers who will provide solutions to challenges, and they can be easily accessed within these pages.
Whether you are looking for a particular company or researching CROs, you will find what you need quickly in the ACT Directory & Buyers' Guide. While clinical trials colleagues communicate with you via the Internet, direct mail or at workshops and conferences, this single-source, desktop print directory will have distinct advantages. The directory is set up with a comprehensive category list and an alphabetized index. The directory also includes a section on professional societies and associations and a calendar of clinical trials events.
I hope our ACT 2006 Directory & Buyers' Guide proves to be an essential part of your desktop reference tools.
Best regards,
Wayne K. Blow
Publisher, Applied Clinical Trials
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
June 26th 2025The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with hemophilia A or B with inhibitors, offering a promising new prophylactic option for a population with limited therapeutic choices.